{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T06:44:38Z","timestamp":1784011478881,"version":"3.55.0"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2010,9,16]],"date-time":"2010-09-16T00:00:00Z","timestamp":1284595200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Leukemia"],"published-print":{"date-parts":[[2010,11]]},"DOI":"10.1038\/leu.2010.160","type":"journal-article","created":{"date-parts":[[2010,9,16]],"date-time":"2010-09-16T10:39:57Z","timestamp":1284633597000},"page":"1927-1933","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":122,"title":["Automated pattern-guided principal component analysis vs expert-based immunophenotypic classification of B-cell chronic lymphoproliferative disorders: a step forward in the standardization of clinical immunophenotyping"],"prefix":"10.1038","volume":"24","author":[{"name":"on behalf of the EuroFlow Consortium","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E S","family":"Costa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C E","family":"Pedreira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S","family":"Barrena","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Q","family":"Lecrevisse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J","family":"Flores","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S","family":"Quijano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J","family":"Almeida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"del Carmen Garc\u00eda- Macias","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S","family":"Bottcher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J J M","family":"Van Dongen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Orfao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2010,9,16]]},"reference":[{"key":"BFleu2010160_CR1","doi-asserted-by":"publisher","first-page":"551","DOI":"10.3324\/haematol.11267","volume":"93","author":"S Bottcher","year":"2008","unstructured":"Bottcher S, Ritgen M, Buske S, Gesk S, Klapper W, Hoster E et al. Minimal residual disease detection in mantle cell lymphoma: methods and significance of four-color flow cytometry compared to consensus IGH-polymerase chain reaction at initial staging and for follow-up examinations. Haematologica 2008; 93: 551\u2013559.","journal-title":"Haematologica"},{"key":"BFleu2010160_CR2","doi-asserted-by":"publisher","first-page":"956","DOI":"10.1038\/sj.leu.2404584","volume":"21","author":"AC Rawstron","year":"2007","unstructured":"Rawstron AC, Villamor N, Ritgen M, Bottcher S, Ghia P, Zehnder JL et al. International standardized approach for flow cytometric residual disease monitoring in chronic lymphocytic leukaemia. Leukemia 2007; 21: 956\u2013964.","journal-title":"Leukemia"},{"key":"BFleu2010160_CR3","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1002\/cyto.b.20178","volume":"72","author":"M Ashman","year":"2007","unstructured":"Ashman M, Sachdeva N, Davila L, Scott G, Mitchell C, Cintron L et al. Influence of 4- and 6-color flow cytometers and acquisition\/analysis softwares on the determination of lymphocyte subsets in HIV infection. Cytometry 2007; 72: 380\u2013386.","journal-title":"Cytometry"},{"key":"BFleu2010160_CR4","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1002\/1097-0320(20010215)46:1<23::AID-CYTO1033>3.0.CO;2-Z","volume":"46","author":"RC Braylan","year":"2001","unstructured":"Braylan RC, Orfao A, Borowitz MJ, Davis BH . Optimal number of reagents required to evaluate hematolymphoid neoplasias: results of an international consensus meeting. Cytometry 2001; 46: 23\u201327.","journal-title":"Cytometry"},{"key":"BFleu2010160_CR5","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1016\/j.cll.2007.05.002","volume":"27","author":"YD Mahnke","year":"2007","unstructured":"Mahnke YD, Roederer M . Optimizing a multicolor immunophenotyping assay. Clin Lab Med 2007; 27: 469\u2013485, v.","journal-title":"Clin Lab Med"},{"key":"BFleu2010160_CR6","doi-asserted-by":"crossref","unstructured":"Wood BL . Ten-color immunophenotyping of hematopoietic cells. Robinson JP et al. (eds). Current Protocols in Cytometry 2005; Chapter 6: Unit 6, p 21. John Wiley & Sons, Inc.: University of Washington, Seattle, Washington, USA.","DOI":"10.1002\/0471142956.cy0621s33"},{"issue":"Suppl 1","key":"BFleu2010160_CR7","doi-asserted-by":"publisher","first-page":"S23","DOI":"10.1002\/cyto.b.20364","volume":"72","author":"B Greig","year":"2007","unstructured":"Greig B, Oldaker T, Warzynski M, Wood B . 2006 Bethesda International Consensus recommendations on the immunophenotypic analysis of hematolymphoid neoplasia by flow cytometry: recommendations for training and education to perform clinical flow cytometry. Cytometry 2007; 72 (Suppl 1): S23\u2013S33.","journal-title":"Cytometry"},{"key":"BFleu2010160_CR8","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1182\/blood-2009-01-197368","volume":"114","author":"WG Nieto","year":"2009","unstructured":"Nieto WG, Almeida J, Romero A, Teodosio C, Lopez A, Henriques AF et al. Increased frequency (12%) of circulating chronic lymphocytic leukemia-like B-cell clones in healthy subjects using a highly sensitive multicolor flow cytometry approach. Blood 2009; 114: 33\u201337.","journal-title":"Blood"},{"key":"BFleu2010160_CR9","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1002\/cyto.a.10101","volume":"58","author":"RC Braylan","year":"2004","unstructured":"Braylan RC . Impact of flow cytometry on the diagnosis and characterization of lymphomas, chronic lymphoproliferative disorders and plasma cell neoplasias. Cytometry A 2004; 58: 57\u201361.","journal-title":"Cytometry A"},{"key":"BFleu2010160_CR10","doi-asserted-by":"publisher","first-page":"1204","DOI":"10.1038\/sj.leu.2404675","volume":"21","author":"R Ratei","year":"2007","unstructured":"Ratei R, Karawajew L, Lacombe F, Jagoda K, Del Poeta G, Kraan J et al. Discriminant function analysis as decision support system for the diagnosis of acute leukemia with a minimal four color screening panel and multiparameter flow cytometry immunophenotyping. Leukemia 2007; 21: 1204\u20131211.","journal-title":"Leukemia"},{"key":"BFleu2010160_CR11","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1002\/cyto.b.20430","volume":"74","author":"MN Dworzak","year":"2008","unstructured":"Dworzak MN, Gaipa G, Ratei R, Veltroni M, Schumich A, Maglia O et al. Standardization of flow cytometric minimal residual disease evaluation in acute lymphoblastic leukemia: Multicentric assessment is feasible. Cytometry 2008; 74: 331\u2013340.","journal-title":"Cytometry"},{"key":"BFleu2010160_CR12","doi-asserted-by":"publisher","first-page":"5130","DOI":"10.1182\/blood-2007-10-119289","volume":"111","author":"S Quijano","year":"2008","unstructured":"Quijano S, Lopez A, Rasillo A, Barrena S, Luz Sanchez M, Flores J et al. Association between the proliferative rate of neoplastic B cells, their maturation stage, and underlying cytogenetic abnormalities in B-cell chronic lymphoproliferative disorders: analysis of a series of 432 patients. Blood 2008; 111: 5130\u20135141.","journal-title":"Blood"},{"key":"BFleu2010160_CR13","doi-asserted-by":"publisher","first-page":"2007","DOI":"10.1038\/leu.2009.140","volume":"23","author":"S Bottcher","year":"2009","unstructured":"Bottcher S, Stilgenbauer S, Busch R, Bruggemann M, Raff T, Pott C et al. Standardized MRD flow and ASO IGH RQ-PCR for MRD quantification in CLL patients after rituxiMAb-containing immunochemotherapy: a comparative analysis. Leukemia 2009; 23: 2007\u20132017.","journal-title":"Leukemia"},{"key":"BFleu2010160_CR14","doi-asserted-by":"publisher","first-page":"834","DOI":"10.1002\/cyto.a.20608","volume":"73","author":"CE Pedreira","year":"2008","unstructured":"Pedreira CE, Costa ES, Barrena S, Lecrevisse Q, Almeida J, van Dongen JJ et al. Generation of flow cytometry data files with a potentially infinite number of dimensions. Cytometry A 2008; 73: 834\u2013846.","journal-title":"Cytometry A"},{"key":"BFleu2010160_CR15","doi-asserted-by":"publisher","first-page":"1141","DOI":"10.1002\/cyto.a.20638","volume":"73A","author":"CE Pedreira","year":"2008","unstructured":"Pedreira CE, Costa ES, Almeida J, Fernandez C, Quijano S, Flores J et al. A probabilistic approach for the evaluation of minimal residual disease by multiparameter flow cytometry in leukemic B-cell chronic lymphoproliferative disorders. Cytometry A 2008; 73A: 1141\u20131150.","journal-title":"Cytometry A"},{"key":"BFleu2010160_CR16","doi-asserted-by":"crossref","first-page":"1850","DOI":"10.5858\/2006-130-1850-FCAOLC","volume":"130","author":"Z Kaleem","year":"2006","unstructured":"Kaleem Z . Flow cytometric analysis of lymphomas: current status and usefulness. Arch Pathol Lab Med 2006; 130: 1850\u20131858.","journal-title":"Arch Pathol Lab Med"},{"key":"BFleu2010160_CR17","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1038\/sj.thj.6200119","volume":"2","author":"ED Rossmann","year":"2001","unstructured":"Rossmann ED, Lundin J, Lenkei R, Mellstedt H, Osterborg A . Variability in B-cell antigen expression: implications for the treatment of B-cell lymphomas and leukemias with monoclonal antibodies. Hematol J 2001; 2: 300\u2013306.","journal-title":"Hematol J"},{"key":"BFleu2010160_CR18","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1136\/jcp.55.3.180","volume":"55","author":"E Matutes","year":"2002","unstructured":"Matutes E . New additions to antibody panels in the characterisation of chronic lymphoproliferative disorders. J Clin Pathol 2002; 55: 180\u2013183.","journal-title":"J Clin Pathol"},{"key":"BFleu2010160_CR19","doi-asserted-by":"publisher","first-page":"1460","DOI":"10.1038\/sj.leu.2402584","volume":"16","author":"ML Sanchez","year":"2002","unstructured":"Sanchez ML, Almeida J, Vidriales B, Lopez-Berges MC, Garcia-Marcos MA, Moro MJ et al. Incidence of phenotypic aberrations in a series of 467 patients with B chronic lymphoproliferative disorders: basis for the design of specific four-color stainings to be used for minimal residual disease investigation. Leukemia 2002; 16: 1460\u20131469.","journal-title":"Leukemia"},{"key":"BFleu2010160_CR20","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1002\/cyto.b.20083","volume":"70","author":"A Ruiz-Arguelles","year":"2006","unstructured":"Ruiz-Arguelles A, Rivadeneyra-Espinoza L, Duque RE, Orfao A . Report on the second Latin American consensus conference for flow cytometric immunophenotyping of hematological malignancies. Cytometry 2006; 70: 39\u201344.","journal-title":"Cytometry"},{"key":"BFleu2010160_CR21","unstructured":"Stetler-Stevenson M, Ahmad E, Barnett D et al. (eds). Clinical Flow Cytometric Analysis of Neoplastic Hematolymphoid Cells: Approved Guidelines. 2nd edn. CLSI document H43-A2 ed. Clinical and Laboratory Standards Institute. Wayne, PA, 2007."},{"key":"BFleu2010160_CR22","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1038\/sj.leu.2405068","volume":"22","author":"E Matutes","year":"2008","unstructured":"Matutes E, Oscier D, Montalban C, Berger F, Callet-Bauchu E, Dogan A et al. Splenic marginal zone lymphoma proposals for a revision of diagnostic, staging and therapeutic criteria. Leukemia 2008; 22: 487\u2013495.","journal-title":"Leukemia"},{"key":"BFleu2010160_CR23","doi-asserted-by":"publisher","first-page":"776","DOI":"10.4065\/83.7.776","volume":"83","author":"WG Morice","year":"2008","unstructured":"Morice WG, Kurtin PJ, Hodnefield JM, Shanafelt TD, Hoyer JD, Remstein ED et al. Predictive value of blood and bone marrow flow cytometry in B-cell lymphoma classification: comparative analysis of flow cytometry and tissue biopsy in 252 patients. Mayo Clinic Proceedings 2008; 83: 776\u2013785.","journal-title":"Mayo Clinic Proceedings"},{"key":"BFleu2010160_CR24","doi-asserted-by":"publisher","first-page":"3835","DOI":"10.1200\/JCO.1999.17.12.3835","volume":"17","author":"NL Harris","year":"1999","unstructured":"Harris NL, Jaffe ES, Diebold J, Flandrin G, Muller-Hermelink HK, Vardiman J et al. The World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues: report of the Clinical Advisory Committee Meeting; Airlie House Virginia, November 1997. J Clin Oncol 1999; 17: 3835\u20133849.","journal-title":"J Clin Oncol"},{"key":"BFleu2010160_CR25","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1002\/(SICI)1097-0320(19990815)38:4<153::AID-CYTO2>3.0.CO;2-E","volume":"38","author":"MG Macey","year":"1999","unstructured":"Macey MG, McCarthy DA, Milne T, Cavenagh JD, Newland AC . Comparative study of five commercial reagents for preparing normal and leukaemic lymphocytes for immunophenotypic analysis by flow cytometry. Cytometry 1999; 38: 153\u2013160.","journal-title":"Cytometry"},{"key":"BFleu2010160_CR26","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1109\/TIT.1967.1053964","volume":"13","author":"TM Cover","year":"1967","unstructured":"Cover TM . Nearest Neighbor Pattern Classification. IEEE Trans Inform Theory 1967; 13: 21\u201327.","journal-title":"IEEE Trans Inform Theory"},{"key":"BFleu2010160_CR27","first-page":"526","volume-title":"Pattern Classification","author":"RO Duda","year":"2001","unstructured":"Duda RO, Hart P, Stork GD 2001. Unsupervised Learning and Clustering. In: Duda RO, Hart PE, Stork GD (eds). Pattern Classification, 2nd edn. John Wiley: New York, 526\u2013527."},{"key":"BFleu2010160_CR28","volume-title":"Principal component Analysis","author":"I Jolliffe","year":"2004","unstructured":"Jolliffe I 2004. Principal component Analysis, 2nd edn. Springer: New York."},{"key":"BFleu2010160_CR29","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1038\/leu.2008.324","volume":"23","author":"R Ratei","year":"2009","unstructured":"Ratei R, Basso G, Dworzak M, Gaipa G, Veltroni M, Rhein P et al. Monitoring treatment response of childhood precursor B-cell acute lymphoblastic leukemia in the AIEOP-BFM-ALL 2000 protocol with multiparameter flow cytometry: predictive impact of early blast reduction on the remission status after induction. Leukemia 2009; 23: 528\u2013534.","journal-title":"Leukemia"},{"key":"BFleu2010160_CR30","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1002\/dc.10268","volume":"28","author":"WA Mourad","year":"2003","unstructured":"Mourad WA, Tulbah A, Shoukri M, Al Dayel F, Akhtar M, Ali MA et al. Primary diagnosis and REAL\/WHO classification of non-Hodgkin's lymphoma by fine-needle aspiration: cytomorphologic and immunophenotypic approach. Diagn Cytopathol 2003; 28: 191\u2013195.","journal-title":"Diagn Cytopathol"},{"key":"BFleu2010160_CR31","doi-asserted-by":"publisher","first-page":"604","DOI":"10.3324\/haematol.2009.011049","volume":"95","author":"L Baseggio","year":"2010","unstructured":"Baseggio L, Traverse-Glehen A, Petinataud F, Callet-Bauchu E, Berger F, Ffrench M et al. CD5 expression identifies a subset of splenic marginal zone lymphomas with higher lymphocytosis: a clinico-pathological, cytogenetic and molecular study of 24 cases. Haematologica 2010; 95: 604\u2013612.","journal-title":"Haematologica"},{"key":"BFleu2010160_CR32","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1002\/ajh.21065","volume":"83","author":"M Goldaniga","year":"2008","unstructured":"Goldaniga M, Ferrario A, Cortelazzo S, Guffanti A, Pavone E, Ambrosetti A et al. A multicenter retrospective clinical study of CD5\/CD10-negative chronic B cell leukemias. Am J Hematol 2008; 83: 349\u2013354.","journal-title":"Am J Hematol"},{"key":"BFleu2010160_CR33","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1016\/j.beha.2007.03.001","volume":"20","author":"E Matutes","year":"2007","unstructured":"Matutes E, Wotherspoon A, Catovsky D . Differential diagnosis in chronic lymphocytic leukaemia. Best Pract Res 2007; 20: 367\u2013384.","journal-title":"Best Pract Res"},{"issue":"Suppl 1","key":"BFleu2010160_CR34","doi-asserted-by":"publisher","first-page":"S14","DOI":"10.1002\/cyto.b.20363","volume":"72","author":"BL Wood","year":"2007","unstructured":"Wood BL, Arroz M, Barnett D, DiGiuseppe J, Greig B, Kussick SJ et al. 2006 Bethesda International Consensus recommendations on the immunophenotypic analysis of hematolymphoid neoplasia by flow cytometry: optimal reagents and reporting for the flow cytometric diagnosis of hematopoietic neoplasia. Cytometry 2007; 72 (Suppl 1): S14\u2013S22.","journal-title":"Cytometry"},{"key":"BFleu2010160_CR35","first-page":"205","volume":"79","author":"H Cualing","year":"1999","unstructured":"Cualing H, Kothari R, Balachander T . Immunophenotypic diagnosis of acute leukemia by using decision tree induction. Laboratory investigation; a journal of technical methods and pathology. Lab Invest 1999; 79: 205\u2013212.","journal-title":"Lab Invest"},{"key":"BFleu2010160_CR36","doi-asserted-by":"publisher","first-page":"215","DOI":"10.3324\/haematol.11622","volume":"93","author":"N Gachard","year":"2008","unstructured":"Gachard N, Salviat A, Boutet C, Arnoulet C, Durrieu F, Lenormand B et al. Multicenter study of ZAP-70 expression in patients with B-cell chronic lymphocytic leukemia using an optimized flow cytometry method. Haematologica 2008; 93: 215\u2013223.","journal-title":"Haematologica"},{"key":"BFleu2010160_CR37","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1002\/hon.888","volume":"27","author":"L Cro","year":"2009","unstructured":"Cro L, Morabito F, Zucal N, Fabris S, Lionetti M, Cutrona G et al. CD26 expression in mature B-cell neoplasia: its possible role as a new prognostic marker in B-CLL. Hematol Oncol 2009; 27: 140\u2013147.","journal-title":"Hematol Oncol"}],"updated-by":[{"DOI":"10.1038\/leu.2010.296","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2011,2,9]],"date-time":"2011-02-09T00:00:00Z","timestamp":1297209600000}}],"container-title":["Leukemia"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/leu2010160.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/leu2010160","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/leu2010160.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T18:03:16Z","timestamp":1684432996000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/leu2010160"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,9,16]]},"references-count":37,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2010,11]]}},"alternative-id":["BFleu2010160"],"URL":"https:\/\/doi.org\/10.1038\/leu.2010.160","relation":{"erratum":[{"id-type":"doi","id":"10.1038\/leu.2010.296","asserted-by":"object"}]},"ISSN":["0887-6924","1476-5551"],"issn-type":[{"value":"0887-6924","type":"print"},{"value":"1476-5551","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,9,16]]},"assertion":[{"value":"29 March 2010","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 June 2010","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 June 2010","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 September 2010","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Cytognos SL is part of the UE-supported EuroFlow Research Consortium, and has implemented some of the algorithms described in the present study, in its proprietary software INFINICYT; Cytognos SL has a contract license of several patents owned by the University of Salamanca, of which A Orfao, CE Pedreira and ES Costa are inventors. Other authors declare no competing financial interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}